Factors Affecting the Price of Dayvigo

Although lemboresant has not been officially launched in mainland China, Eisai, a Japanese company, has submitted a marketing application for lemboresant to the National Medical Products Administration (NMPA). 

Factors Affecting the Price of Dayvigo

The application has been accepted, and the launch process in China is underway. Currently, patients in mainland China cannot directly purchase this drug through regular pharmacies or hospital pharmacies. 

Lemborexant has been launched in Hong Kong, China, and dozens of other countries and regions including the United States, Japan, Canada, and Australia. Patients can obtain the drug through overseas purchases or medical service agencies. Regardless of the channel, patients should ensure the drug comes from regular sources and has reliable quality, avoiding those with unknown origins or unguaranteed quality.